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Analysis of the hair fiber for scheduled drugs, therapeutic drugs, or other 
xenobites which bind to the hair shaft has become a useful tool in forensic investigations. 
Specific digestion-extraction procedures have been developed for a variety of basic and 
acidic drugs, however, development of a comprehensive, general screening method to 
confirm the presence of multiple drugs in different drugs classes using one analytical 
technique has not been reported. This paper explores the development of a digestion- 
extraction procedure for drugs in the following classes: amphetamine-like compounds, 
benzodiazepines, opiates, cocaine and cocaine analogs, barbiturates, tricyclic 
antidepressants, and the drug propoxyphene. The development of a sensitive analytical 
procedure to determine and confirm drug presence in the hair fiber and a novel approach 
to differentiate between endogenous and exogenous drug binding are discussed.
Throughout a two year period 26 postmortem human hair samples were collected 
from county coroners across the state of Montana. Routine toxicological analysis of urine 
and blood samples were performed prior to hair analysis; however, the results of this 
screening were not known until the conclusion of the project. Hair analysis revealed the 
presence of 42 drug confirmations, 10 of which were not identified in the urine, and 25 
which were not identified in the blood. These data strengthen the validity of the 
developed digestion-extraction and analytical procedures and support the role of hair 
analysis as a supplemental screen in forensic toxicology.
A novel approach to differentiate between endogenous and exogenous drug 
exposure was explored using anti-opiate monoclonal antibodies. The study was initially 
designed using a rat model; however to expand the findings in the preliminary study, a 
similar protocol was applied to human hair. Positive and negative controls, in addition to 
two case samples containing hydrocodone, were sectioned at 5 microns, mounted on 
microscope slides, and immunocytochemistry was performed. The human hair controls 
differentiated between the staining patterns of drug versus non-drug controls, determined 
by the characteristic brown staining of diaminobenzidine. While preliminary 
investigations reveal this protocol as a viable method of exogenous drug detection, 
further research is needed to explore the possibilities of using antibodies as a method of 
detection for exogenous drug contamination in additional drug classes.
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Chapter 1. Background
I. Introduction
Human hair serves a variety of functions for the human body ranging from 
environmental protection to thermal insulation. On a macro-scale, hair provides a visual 
differentiation between humans, based upon color, shape, and length of hair. On a micro­
scale level, hair is a complex network of fibers and vacuoles that have the capacity to store 
information about an individual’s lifestyle. This lifestyle information is derived from 
xenobites bound in the hair fiber. Analysis of the hair fiber for scheduled drugs, 
therapeutic drugs or other xenobites which bind to the hair shaft, provides an extended 
exposure history which other biological samples do not provide. Pubic, beard, auxiliary, 
and head hair have the capability to bind drugs within the hair fiber. Head hair is the most 
common hair type studied in research facilities across the United States. (1,2)
The simplest model proposed for the incorporation of drugs into hair theorizes that 
drugs enter the fibril by passive diffusion from the bloodstream into the growing hair cells 
at the base of the hair follicle, and then become tightly bound in the interior of the hair 
shaft during keratogenesis. However, more complex models which consider drug 
deposition from sweat, distribution volume, pharmacokinetics and drug lipophilicity have 
been invoked to explain variables such as the concentration differences in hair of various 
individuals receiving the same dose of drugs, as well as to clarify why drug concentration 
and metabolite ratios in hair are quite different from those found in blood. (3)
In 1990 the Society of Forensic Toxicologists (SOFT) issued a consensus opinion
summarizing the current applicability of hair analysis for testing for drugs of abuse:
“ the use of hair analysis for workplace drug testing [is] premature and
interpretation of test results [are] insupportable with current information. Hair is a 
useful specimen in forensic investigations when supported by other evidence of 
drug use.”
At the time, no generally accepted procedures for hair analysis were available and the 
accuracy, precision, sensitivity, specificity, and cutoff levels defining positive and negative 
test results were not established. Reference materials (to standardize analytical methods) 
were not available and many important questions remained regarding incorporation, 
retention, stability and analytical detection of drugs in hair. This prompted an explosion of 
research over the next several years.
Specific digestion-extraction procedures have now been developed for a variety 
of basic and acidic drugs including phencyclidine, methadone, codeine, flunitrazepam, 
heroin, cocaine, cannabis, ketamine, carbamazepine, nicotine, and morphine. 
(4,5,6,7,8,9,10) These procedures have become more reliable, allowing researchers to 
address more complex issues such as dose-response and binding kinetics, but development 
of a comprehensive general screening method to test for several drug classes using a 
single digestion-extraction technique has not been reported. A cost-effective, time- 
efficient screening method for hair would be valuable to the forensic community, both as a 
supplemental toxicological screen and as an investigative tool to future researchers.
The development of a general screening procedure for drug analysis in hair is the 
principle purpose of this report. The research involves the following specific aims:
1. Development of a digestion procedure for:
a), fortified hair; negative (drug free) hair soaked in a drug solution 
b.) non-fortified hair, or case samples;
2. Development of an extraction procedure for the following drugs and drug 
classes: amphetamine/amphetamine analogs, benzodiazepines, opiates, 
cocaine, propoxyphene, barbiturates, and tricyclic antidepressants;
3. Development of a sensitive analytical procedure for the presumptive 
determination and the confirmation of drugs in human hair.
n. History o f Hair Analysis
Since the early 1960's, scientists have used hair as a biological tool of discovery. 
The morphology and physiology of hair provides a unique matrix for recording exposure 
information of environmental substances over a longer time period than other biological 
samples (such as blood or urine). The importance of hair analysis increased when 
researchers realized that hair could store heavy metals along the hair shaft in a time-course 
dependant manner with most recent exposure being recorded in the proximal hair segment. 
The time-course relationship of metal deposition along the hair fiber sparked interest in the 
possibility of obtaining the drug history of a chronic drug user in the hair shaft. Most 
abused drugs and several therapeutic drugs have been detected in the hair of chronic users. 
(11) Hence, hair analysis has been proposed to investigate drug abuse for epidemiological, 
clinical, administrative and forensic purposes.
In the 1980's, William Baumgartner and associates began investigating which 
drugs bind in/on hair. As more information became available regarding how drugs 
associate with the hair fiber, scientists began to question decontamination processes in
relation to exogenous drug exposure. Investigators began to focus more attention on wash 
protocols and the binding kinetics for specific drugs or drug classes in an attempt to 
validate the usefulness of hair as a biological tool in forensic cases.
The toxicological specimens analyzed in the most medico-legal cases are 
biological fluids such as blood, urine, and vitreous humor. However, in some instances, 
hair is the preferred matrix for forensic investigation. Historic hair, such as that of 
Napoleon, has been analyzed to determine if the cause of his death was acute arsenic 
poisoning. (12) In this case, hair was the only biological sample available for analysis 
(versus blood, urine, or tissue). In other instances, hair analysis is preferred because it is 
less invasive than urine or blood analysis, as in cases where children are involved. (13)
Hair analysis is beginning to play a greater role in criminal investigations as scientists 
learn more about the drug-hair interactions that make identification of drug exposure 
possible. To elucidate the interactions of drugs and hair, investigators are further 
exploring the relationships between and within the micro-structure of the hair fibril. The 
applicability of hair analysis to a wide range of drugs is beginning to come into focus as 
more scientists experiment with digestion-extraction models which target a particular 
structural component of hair, such as melanin, 
m. Characteristics o f Hair
A. Anatomy
Human hair is a fiber-like substance which covers a majority of the human body. It 
serves to protect, insulate, and stimulate responses on the skin. Hair is composed of 
cylindrical structures or shafts made up of tightly compacted cells which grow from small
sac-like organs called follicles. The diameter of individual hair shafts in man range from 
15 to 120 micrometers (wm), Figure 1.
Each hair shaft is made up of three distinct types of cells. The cuticle, the outer 
most layer of the hair shaft, is scale-like in nature. The single layer of elongated, 
overlapping individual cells is 0.5 to 1.0 um thick and approximately 45 um long. The 
mechanical stability provided by the cuticle anchors the hair shaft in the follicle and 
protects the inner regions of the hair shaft by acting like plated armor. The cuticle also 
hinders exposure of the hair shaft to exogenous substances which could degrade the 
integrity of the inner hair. The cuticle may become damaged or destroyed by chemicals, 
heat, light, or mechanical injury, resulting in a less intact (frayed) structure toward the 
distal end of the shaft. Figure 2. (14)
The cortex lies under the cuticle. The cortex forms the bulk of the hair shaft and is 
composed of keratinized cells which form fibers approximately 100 um long. Cortical 
cells are spindle-shaped cells which contain fibrous proteins that enclose small spaces 
called fusi. In the living portion of the hair root, these sacs are filled with fluid. Air 
replaces the fluid as the hair shaft matures and dries out. Pigment granules are also found 
in cortical cells. Melanin is the primary pigment of hair, skin, and eyes. Melanin is 
synthesized in specialized organelles called malanosomes which are located within 
melanocytes in the hair bulb. The enzyme tyrosinase converts the amino acid tyrosine to 
melanin. Figure 3.
On the most interior portion of the hair shaft is the medulla. Medullar cells are 
initially loosely packed. As the hair grows, these cells dehydrate and shrivel up to leave a
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Figure 2. Scanning electron micrograph of a split hair. Note cortical cell fragments, 
which appear as “broomlike” fractures. Chemical and Physical Behavior of Human Hair. 
3̂  ̂Ed. Springer 1994.
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in Hair (1996)
series of vacuoles along the fiber axis. The medulla functions to provide the major 
pathway of diffusion into the fibers of the cortical region.
Mature hair fibers contain at least two of the three structures described above. In 
human hair, medullar cells comprise only a small percentage of the mass of the hair shaft 
and may be completely absent, continuous or discontinuous along the center of the hair, or 
double (as in human beard hair).
The micro-structure of hair is essentially a cross-linked, partially crystalline 
oriented polymeric network. Human hair contains relatively large amounts of the 
following amino acids: hydrogen side-chain (glycine), hydroxyl side-chain (threonine), 
primary amide (aspartic and glutamic acid), mono-basic (lysine), thiol (cysteine), and 
phenolic (tyrosine). Hair also contains proteins (65-95%), lipids (1-9%), and water (15- 
35%). (14)
The outer surface of the mature hair shaft has three distinguishable zones. Figure 4. 
Synthesis and orientation of the hair take place in zone one, the zone of differentiation and 
biological synthesis. Keratinization occurs at the bulb end, zone two. In this region, the 
hair becomes stabilized through the formation of cysteine cross-links between keratin 
molecules. Zone three is the permanent hair fiber, which is characterized by the 
dehydrated nature of the cuticle.
B. Types of Hair
Hair on the human body is classified into three groups of hair fibers based upon 
the differences in length, texture, color, diameter, and shape. Vellus hair is very fine, short 
(less than 1 cm), non-pigmented hair that is on the seemingly hairless parts of the body
10
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such as eyelids, forehead, and the bald scalp. Course hair, called terminal hair, is longer 
(greater than 1 cm), and contains pigment. Terminal hair is found on the “hairy” parts of 
the body; the scalp, beard, eyebrows, and eyelash. The third classification of hair, 
intermediate hair, is intermediate in length (approximately 1 cm) and shaft size, and is 
found on the arms and legs of adult humans.*
These three types of hair are produced from three corresponding follicles. 
Intermediate hair is produced by non-sexual hair follicles found along the arms and legs in 
males and females. Non-sexual follicles are not influenced by hormonal changes and do 
not change hair type after puberty. Ambosexual hair follicles cover the axilla, pubic, and 
temple areas of the male and female body. These follicles are sensitive to hormonal 
changes. Vellus hair produced by the ambosexual hair follicle in the armpit and pubic 
areas of the body changes to terminal hair with the onset of puberty. In the temple region, 
terminal hair changes to vellus hair to result in the characteristic reshaping of the facial 
outline. Sexual hair follicles are the third type of follicle and are unique to males. These 
follicles are found in the beard, ear, nose, chest, and abdomen areas of the male. At 
puberty, these follicles respond to increased androgen levels by changing production of 
vellus hair to terminal hair. Interestingly, baldness in males is not a disease, but a 
condition in which the sexual follicles in the anterior vertex area of the scalp revert from 
producing terminal hair to vellus hair.
C. Growth
Hair moves through three phases of growth before it reaches maturation. The first 
phase is the actual growth phase of fiber and is called anagen. Anagen is further
12
subdivided into six substages (I to VI). Substages I through V are collectively called 
proanagen and are defined by progressively higher levels of new hair tip position within 
the follicle. The VI substage, metanagen, is defined by the emergence of the hair shaft 
above the skin surface. Human scalp hairs have a relatively long hair cycle with the 
anagen stage typically ranging from 2 to 5 years. (15) The hair then enters into the second 
stage of the growth cycle known as catagen.
The catagen stage of the growth cycle is a degenerative stage in which cell division 
stops and the base of the hair shaft becomes fully keratinized and forms the dry, white 
node characteristic of a “club” hair. Figure 5. (14) As the bulb degenerates, the follicle 
becomes considerably shorter. Human scalp hair generally has a short catagen phase of 
several days.
Telogen represents the final stage of the growth cycle, the resting stage. Normal 
telogen is approximately 3 months in adult scalp hair. Once a hair follicle has made the 
transition to telogen, its existing hair will never grow longer. The club-shaped proximal 
end within the hair follicle will typically be shed from the follicle during telogen or during 
the subsequent anagen.
Morphological changes in the hair shaft may be tracked throughout the growth 
cycle. Figure 6. During anagen, the follicle penetrates deepest into the skin, typically to 
the level of subcutaneous fat. Catagen is heralded by pyknotic changes in the nuclei of 
hair kératinocytes followed by apoptosis within the transient portion of the follicle. The 
entire transient portion of the follicle is reabsorbed except for the basement membrane 
(glassy membrane), which folds up like an accordion bellows, causing follicular retraction
13
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Figure 6. Schematic illustrating the three stages of growth of the human hair fiber. 
Chemical and Physical Behavior of Human Hair. 3"* Ed. Springer 1994.
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and associated higher placement of the papilla remnants (located at the base of the root 
bulb) within the dermis. The inner root sheath, which disintegrates during anagen at the 
level of the sebaceous duct, is totally absent from the telogen follicle.
A complete description of growth regulation for hair is still unclear. However, 
several relationships have been recognized. Simple observation leads us to believe that 
there is a genetic program that specifies normal growth parameters for hairs located on 
different anatomical locations of the human body such as the eyebrows, scalp, auxiliary, 
and facial areas. This type of regulation is the innate programming of the follicle and 
likely specifies such features as hair cycle duration, rate of hair production, type and 
quality of hair, and sensitivity to other growth hormones. Additionally, hair growth may 
be greatly influenced by various hormones including thyroid hormones, corticosteroids, 
and sex hormones; for example, androgens are known to up-regulate the pubic, axillary, 
and beard hair but down-regulate genetically predisposed scalp hair follicles in common 
baldness. In addition, morphometric analysis of the hair follicles from the middle back 
region of spontaneous anagen mice that received parathyroid hormone suggests that this 
hormone-related peptide may be a major factor responsible for controlling the hair cycle in 
this species of rat. (16) The growth rate of each type of hair is different both between 
classes (terminal, axillary, vellus) and within a class. The difference between classes may 
be explained in part due to the different functions the respective hair type serves. For 
example, if the function of hair is to warm the body, it can be anticipated that long, thick 
hair will occur on the head of the body where humans lose 90% of their body heat.
16
1. Segmented Hair Analysis
While the variance of growth rates for hair type is complex, it is this feature 
of hair that offers researchers the possibility to obtain a timetable of drug exposure. (17) 
The principle of a chronological interpretation of drug concentrations in hair segments is 
based on the following assumptions detailing segmental hair analysis:
■ the drug is incorporated from the bloodstream into the hair root within a 
limited time period
■ there is a constant (and known) hair growth rate, as well as a fixed position 
and stable concentration of drugs in the growing hair shaft
■ negligible additional competitive incorporation mechanisms which would 
lead to additional deposition sites along the hair shaft
■ negligible physical or chemical elimination of the drug from the hair shaft 
(through normal hygiene practices or cosmetic applications) that would lead 
to a change of the initial segmental concentrations during the hair lifetime 
Under the above conditions, the time of the drug consumption can be
calculated from the drug position in the hair shaft using the following equation:
Ti = (Ts - li)(Vh-lr)/(Vh-To)
Where Ti=time of the drug intake; Ts= time of the hair sampling; To= time between 
incorporation of the drug into the hair root and appearance at the skin surface; li= distance 
of the drug position in hair from the proximal end of the hair sample; lr= length of the 
residual hair shaft from the skin surface after sampling; and Vh= hair growth rate. (18)
This model indicates that the accuracy of hair analysis for the estimation of Ti increases
17
with decreasing segmental length.
The analysis of segmented hair analysis should be interpreted very cautiously. The 
variability in growth rates, drug deposition along the hair shaft from sweat/sebum, drug 
redisposition within/along the hair fiber, variable exposure to weather (photochemical 
destruction of hair pigments), and undefined growth parameters for postmortem samples 
prevented segmental analysis in this research study.
D. Hair Pigmentation
Melanin is one of the factors believed to be involved in binding drugs into hair. 
Melanocytes located above the follicular papilla in the matrix area of the follicle produce 
the pigments. Pigment-laden extensions of the melanocytes move out along the 
differentiating hair kératinocytes. Each follicle produces only one of the two types of 
pigment, eumelanin or pheomelanin. These pigments are polyanionic polymers with a 
high content of negatively charged carboxyl groups and o-semiquinones. Eumelanin is a 
brown-black polymer of dihydroxyindole subunits synthesized from the precursor amino 
acid tyrosine. This melanin has a quinone-like structure and is highly anionic. (4) 
Pheomelanin is also synthesized from the precursor tyrosine; however, biosynthesis 
involves the incorporation of a cysteine residue into benzothiazine derivatives. 
Pheomelanin is a reddish-yellow pigment.
Melanins are incorporated among the keratin fibrils of hair. (6) The varying shades 
of natural hair color are determined by the quantity of these two pigments in the hair fiber. 
Substances with cationic groups under physiological conditions, such as amines and 
metals, bind to eumelanin by ionic interactions. Figure 7. (5) The ionic bonding is
18
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presumably strengthened by non-electrostatic contributions such as van der Waal’s forces 
at the conjunctions of the aromatic rings in the xenobite and the aromatic indole nuclei of 
the melanin. (6) Green and Wilson have suggested that following penetration of the 
melanocyte, drugs interact with a melanosomal protein and melanins. (19) This binding is 
complex. Scatchard analysis shows more than one type of binding for individual 
substances, and implicate both cooperating binding mechanisms and stearic factors. (6) 
Drugs which are cations at physiological pH 7.4 are incorporated into hair to a greater 
extent than those drugs which are anions. (5) This finding supports the role of eumelanin 
in drug binding. The role of pheomelanin in drug binding has not been established.
E. Effect of Hair Cosmetics on Drug Analysis in Hair
One issue of concern for drug analysis in hair is the change in the drug 
concentration induced by popular cosmetic treatments of hair such as bleaching or 
permanent waving. The products used for these treatments are generally strong bases 
which affect the stability of incorporated drugs and cause alterations of the fibers at an 
ultra structural level. (20) Partial or complete loss of drug substances may result from a 
“more permeable” hair fiber. Although “permed” and bleached hair shows an enhanced 
absorption capacity, investigators revealed that an increased risk of confirming drugs from 
exogenous origin with these treatments does exist, but the risk is not particularly severe. 
(21)
Chapter 2. Development of Decontamination, Digestion, Extraction and 
Analytical Procedures
/. Drugs Included in Study
In 1996 the Montana State Crime Laboratory concluded a two-year study 
undertaken to determine whether or not MCA 61-8-402 (prohibitive Driving Under the 
Influence of Drugs legislation) should be amended. In this study, drug levels from 744 
individual subjects were recorded, as well as the age, gender, race, and blood alcohol 
concentration. Drug occurrences by class were as follows: barbiturates (3%), 
benzodiazepines (15%), amphetamine and amphetamine analogs (11%), opiates (7%), 
tricyclic or other antidepressants (5%), cocaine or cocaine metabolites (3%). (32) Drugs 
included in this study protocol were based upon the above statistics detailing the 
prevalence of abuse for Montana as well as the ease of chromatography/spectrometry of 
the drug (based upon literature searches) and the assays available for the presumptive 
screening instrument, the Enzyme Multiplied Immunoassay Technique (EMIT). In 
addition to the above six drug/drug classes, we also included propoxyphene (which is a 
synthetic opiate).
A. Length of Detection for Drugs in Hair
The time between drug incorporation and appearance of the drug in the hair fiber 
(at the skin surface) will vary between drugs based upon unique chemical properties of 
each drug (such as pH, bioavailability, stearic factors, competitive mechanisms, and 
elimination rates). However, using an average growth rate of hair and the distance a 
growing fiber must travel before emerging from the skin (the distance between the matrix 
cell level and the level of complete keratinization, 1.2-1.5 mm), the To, time between
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incorporation of drug and appearance at skin surface, can be estimated between 9 and 14 
days. (33) In contrast to physiological expectance, in most cases the drug is first detected 
between 6 hours and 4 days after application. The short appearance time To (in shaved, 
not pulled hair) is also confirmed by experiments with guinea pigs, rabbits and rats. 
(34,35,31)
B. Limit of Detection for Instrumental Analysis
The large number of drugs in each drug class prevents the generalization of an 
overall limit of detection (LOD). However, when possible, 1 or 2 prototypical drugs from 
each class were analyzed to become more familiar with parameters such as LOD for the 
instrument. All limits of detection are derived from fortified hair samples and are in 
reference to the detection of the drug by the gas chromatography-mass spectrometry 
(GC7MS). The LCD’s are calculated using the following example calculation:
Step 1 lOOng drug/ 1 milligram hair sample = 1000 ng drug total (analyzing 10
milligrams hair)
Step 2 1000 ng drug/350 micro-liters methanol (reconstitution) = 2.856 ng drug/
mirco-liter methanol
Step 3 2 micro-liters methanol/ injection = 5.71 ng drug / injection on GC/MS
Several experiments were designed in this manner and their results are summarized in 
Table 1. Following Table I is a graphical representation of the LOD study.
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Table 1, Limit of detection for variety of drugs included in the study. Prototypical drugs were chosen from 
several of the drugs classes of interest to determine a representative limit of detection for analytical 
purposes.*
DRUG AMOUNT DRUG DETECTED (NANOGRAMS)
Fentanyl 30
Methadone 30
Oxycodone 30
Codeine 11.42
Benzphetamine (Internal Standard) 11.42
Papaverine 11.42
Amitriptyline 5.71
Imipramine 11.42
Nortriptyline 30
Carbamazepine 30
Fluoxetine 30
Caffeine 30
Propoxyphene 5.71
Tramadol 30
Norpropxyphene 11.42
Amphetamine 11.42
Methamphetamine 5.71
Fenfluramine 2.9
Ephedrine 11.42
Phenteramine 30
Chlorpheniramine 30
Lidocaine 5.71
Flurazepam 30
Midazolam 30
Triazolam 30
Alprazolam 30
Chlordiazepam 30
Chlordiazepoxtde 5.71
* LOD’s were determined using 10 milligrams of hair fortified with 1000 nanograms of drug.
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The information provided by the LOD study serves to initiate a better 
understanding of the limits of the analytical method. This information must be interpreted 
with caution, providing only a representation of the quantity of a drug which can be 
detected in human hair. Additional research is needed to further the quantitative 
description of limits of detection in non-fortified positive human hair samples.
Graph 1: Four series of extractions, beginning at a drug level of 200 nanograms (per 10 milligram hair) and 
ending at < 15 nanograms, were utilized to estimate the limit of detection for one prototypical drug of 6 drug 
classes on the GC/MS.
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Although exact mechanisms of drug binding in the hair fiber are not known, it is 
apparent that drug may be deposited in hair by multiple routes including the bloodstream 
(endogenous), sweat and sebaceous glands, and from environmental exposure 
(exogenous). (22) The earliest theoretical position explaining the incorporation of drugs
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into hair is known as the Entrapment model. In this model, drugs present in the 
bloodstream are entrapped in inaccessible regions of the hair during the hair growth 
process. After the hair emerges from the scalp, these “entrapped” drugs form bands along 
the hair fiber that are in direct proportion to the concentrations present when the hair was 
formed. This model proposes that the entrapped drugs are protected by the hair matrix 
from removal or change by the external environment (normal hygiene processes). A 
second model, the Sweat model, suggests that some drugs may be incorporated into the 
hair fiber as described above, via the bloodstream. However, water-soluble drugs are also 
excreted into the sweat and sebum which bathe the hair at the base of the hair shaft. These 
water-soluble drugs, which are secreted in the sweat and sebum, come in contact with the 
hair on the exterior of the skin. This model follows several different approaches when 
compared to the Entrapment model. The Sweat model predicts few or no regions in the 
hair that are inaccessible to the external environment, and drugs in the hair fiber are 
deposited from three sources: blood, sweat/sebum, and passive exposure (environmental 
exposure).
The possibility of exogenous exposure in the forensic setting dictates the need for a 
decontamination step before the hair sample is digested. Some investigators indicate that 
exposure from exogenous and endogenous sources can be distinguished through specific 
washing procedures and the use of mathematical algorithms. (23) However, other 
investigators report that unless the contamination is very heavy, there is no consensus as to 
which samples are externally contaminated. Unfortunately, decontamination washes 
remove endogenous drugs as well as exogenous drug. (24,25) Therefore, we needed to
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identify a wash protocol that extracts the least amount of an endogenous drug while still 
removing drugs on the exterior of the hair fiber.
In this project, five common wash solvents were selected for evaluation based 
upon their prevalence in published literature: methanol, methylene chloride, MilliQ water, 
phosphate buffer, and sodium dodecylsulfate. (1) Quantitative data show phosphate 
buffer and sodium dodecylsulfate extract at least 30% of endogenous drug from the hair 
fiber in rat models whereas methanol, methylene chloride, and water extract no more than 
20% of endogenous drug. Water is the least invasive solvent, extracting approximately 
13% endogenous drug (values are expressed as percent decreases in measured 
concentrations as compared with non-washed hair values in nanogram drug/milligram 
hair).(26) Based upon these findings, deionized water was selected for the wash protocol 
in our study (see Appendix One).
///. Digestion
The digestion process refers to the initial stage of hair analysis in which the 
macro-structure of the hair is degraded by chemical (liquid solvent) or mechanical 
(pulverized) methods. Chemical solubilization results in a dénaturation of cysteine 
linkages (through reduction) and structural proteins through either high or low pH. The 
end stage of digestion in this project is determined by the length of contact time between 
the hair samples and the digestion solvent. In other words, the digestion period is 
concluded after a specified length of time has passed (3-4 hours). Complete digestion 
refers to the complete breakdown of all hair fibers in the sample of interest as determined 
by visual observation.
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The following digestion techniques were incorporated into the study based upon 
their prevalence in the literature: acidic (hydrochloric acid), enzymatic (Tris buffer, 
dithiothreitol, proteinase K, and sodiumdodecyl sulfate), and basic digestion (sodium 
hydroxide). These three techniques were analyzed to determine which digestion would 
provide the single best procedure to detect the largest variety of drugs based upon recovery 
studies of the drugs using spectral data obtained on a GC/MS.
The basic and acidic techniques provided digestion of the hair sample and both 
these samples were extracted (as described in Appendix 2). The enzymatic technique did 
not digest the hair sample, even after 24 hours of contact, and therefore was not extracted 
or further analyzed. A comparison of the spectral data from the basic and acidic samples 
established the basic digestion procedure as the superior digestion technique by the 
increased number of drug confirmations. Based upon the results of our initial 
experiments, we chose to pursue a technique that incorporated a basic digestion of the hair. 
This finding is supported in the literature when comparing the reproducibility of 
dissolution and extraction efficiencies of enzymatic and pH related digestions respectively. 
(27,28)
A. pH Effecting Drug Degradation
To investigate the severity of drug degradation caused by pH extremes, one 
experiment was designed using drug solutions in place of fortified hair samples. The drug 
solutions were exposed to 0.01,0.5, and 1.0 N sodium hydroxide, the basic digestion 
solvent, for the initial digestion step for 3-4 hours. The drug solutions were then exposed 
to a pH change, using buffers, to achieve a final pH <6 or a pH>13. This step mimics (in
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an extreme example) the possible environment of the hair sample coming from a digestion 
step with very high pH range, to an extracting environment, with a lower pH range 
(pH~9). To determined extent of degradation to individual drugs, the results from each 
analyzed drug solution were compared to non-processed drug solutions prepared at 
equivalent drug concentrations. Degradation was apparent for cocaine, benzodiapezines, 
barbiturates, propoxyphene, and amphetamine assays at all pH ranges, as determined by a 
comparison of EMIT rates (see Chapter 3) of the drug solutions exposed to pH changes 
versus rates of drug solutions not exposed to any change in pH. However, when the 
experiment was repeated with the addition of a buffering step (sodium borate solution, pH 
9.2) prior to the initial “digestion” of the drug solution, cleaner baselines and sharper 
spectral peaks were detected on the GC/MS and equivalent rates were observed between 
“digested” drug solutions and non-processed controls on the EMIT with the higher pH 
(pH>13) extract versus the lower pH (pH<8) extract.
IV. Extraction
The study investigated solvents that best extracted drugs out of the solublized hair 
media. These solvents included n-butyl chloride, chloroform, hexane, and 
chloroform:isopropylalcohol (4:1). In addition to liquid-liquid extraction, solid phase 
extraction was investigated using a 200 milligram CLEAN SCREEN™ EXTRACTION 
COLUMN (See Appendix One).
In the extraction experiments, fortified hair (negative hair soaked overnight in a 
drug/methanol solution) was analyzed to determine which extraction technique provided 
the best recovery of a drug from the hair when compared to non-processed controls, based
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upon EMIT rates and GC/MS mass ratios. The liquid extraction utilizing n-butyl chloride 
provided the cleanest extraction for all of the drugs analyzed, as determined by the total 
mass ratio (total area for all peaks in the chromatogram) and number of extraneous peaks 
(noise) identified using the GC/MS.
A. pH Effecting the Extraction Efficiency
The development of a general analytical method required the inclusion of a large 
variety of drugs into one digestion-extraction procedure. Based upon the first set of 
experiments regarding the digestion solvent, a basic solvent was best to solublize the hair 
fiber. This alkaline pH could make the extraction solvent less efficient in pulling the 
drugs from the digestion solution. To explore this issue, an experiment was done using 
five hair samples weighing approximately 10 milligrams each. These samples were 
fortified with the following drugs solublized in methanol: amphetamine, 
methamphetamine, chloropheniramine, lidocaine, meperidine, codeine, oxycodone, 
amitriptyline, caffeine, and the internal standards benzphetamine and papaverine. The five 
samples were fortified at equivalent concentrations for a period of 24 hours (overnight). A 
negative control, with internal standards, and a positive fortified control were analyzed 
parallel to the five samples and served as quality controls. The five samples were digested 
in 1 N sodium hydroxide for one hour with constant stirring in a hot water bath of 60 ° 
Celsius. Samples were allowed to cool to room temperature and the pH was adjusted to 6, 
8,9,10, and 13 using 1 N HCl, the negative and positive controls were kept at a constant 
pH 13. The samples, including the negative and positive controls, were extracted and 
analyzed as described in Appendix One. The “cleanest" extraction, based upon EMIT
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rates and baseline noise observed on the GC/MS was achieved using the n-butyl chloride 
at a basic pH 13.
B. Volatility
A difficultly involving the detection of amphetamine-like drugs in fortified hair 
using our preliminary screen with the EMIT was observed. This prompted exploration 
into the volatile nature of amphetamine and the effect of digestion temperature on drugs 
such as amphetamine and amphetamine analogs. Amphetamine slowly volatilizes at room 
temperature. Volatilization becomes negligible if silanized glass test tubes are used and 
the tubes are capped (allowing the tubes to cool to room temperature before opening).
To determine how the increased temperature of the digestion bath was affecting the 
volatile nature of amphetamine like compounds, triplicate sets of three positive hair 
samples were fortified overnight using drug solutions, as described in the preceding 
section. The digestion solvent was 1 N sodium hydroxide. Each of the three samples was 
placed in water baths of 30,45, and 60 degrees Celsius for 30,60, or 120 minutes 
respectively. One sample was left in the 30-degree water bath for more than 180 minutes. 
The samples were then extracted and analyzed as described in Appendix One. An inverse 
relationship between water bath temperature and length of digestion time was observed. 
We were able to detect amphetamine and amphetamine-like compounds at the lower 
temperatures (>40 degrees Celsius). However, longer digestion time was required to 
achieve solubilization of the hair fibers, based upon visual observation.
V. Analytical Procedures
Throughout the history of forensic hair analysis, many instrumental methods have
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been employed to identify drugs, including radioimmunoassay, high-performance liquid 
chromatography, and gas chromatography-mass spectrometry(GC-MS). One type of 
presumptive screen utilized for determining the presence of drugs of abuse in biological 
samples is the EMIT. The EMIT assays provide qualitative analysis of blood and urine 
specimens for the presence of the following classes of drugs of abuse: amphetamines, 
barbiturates, benzodiazepines, cannabinoids, cocaine, opiates, and propoxyphene. The 
assays utilize a homogeneous enzyme immunoassay technique. Samples are mixed with 
two reagents:
1.) Reagent A contains antibodies to a particular drug, the coenzyme nicotinamide 
adenine dinucleotide (NAD), and a substrate for the enzyme glucose-6-phosphate 
dehydrogenase (G6P-DH).
2.) Reagent B contains a drug derivative labeled with the G6P-DH enzyme.
When reagents are added to the sample, the antibody binds to the drugs it recognizes, and 
the enzyme-labeled drug combines with the remaining antibody binding sites, decreasing 
the enzyme activity. Some enzyme remains unbound and, therefore, stays active in the 
reaction mixture. This residual enzyme activity is directly related to the concentration of 
the drug in the sample. The active enzyme converts NAD to NADH, resulting in a 
photometric absorbance change. By comparing the absorbance change for a sample with 
that of the cutoff calibrator that contains a known quantity of drug metabolite, drug 
presence in the sample can be determined. Three calibrator levels are provided for each 
assay: negative (drug free calibrator), cutoff (the cutoff, or low calibrator), and high (the 
positive calibrator). The reaction rate of the cutoff calibrator serves as the reference point
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for determining samples results. A sample is considered positive if its reaction rate is 
equal to or greater than that of the cutoff calibrator. Negative and positive calibrators are 
analyzed as controls to validate reagent and instrument performance. Each assay takes 
approximately 1 minute to complete. The variety of assays coupled with the brief analysis 
time made this instrument ideal for a presumptive screen for hair analysis.
While there are a variety of presumptive screens which are acceptable for drug 
analysis, currently, the most reliable, sensitive, and specific method of analysis used to 
confirm the presence of drugs in hair is gas chromatography-mass spectrometry (GC-MS). 
(29) The underlying chemical and physical properties of the drug such as pka, solubility, 
and functional groups determine which instrumental parameters are selected to afford 
better separation and identification of the drugs of interest. Fragmentation patterns of 
xenobites are obtained through either one of two ionization modes, electron ionization 
(El), or chemical ionization (Cl). In positive-ion El, positively charged sample ions are 
formed when electrons from the filament ionize sample molecules as follows:
(S) + (e-) = (S+) + (2e-)
The energetic electron that interacts with the sample molecule often deposits more energy 
in the sample molecule than is needed for ionization alone, therefore, the sample ion, S+, 
often decomposes through a complex series of unimolecular decomposition, with charged 
and neutral fragments. The MS detector determines the masses and abundances of the 
various ions present, and a plot of this information is the familiar positive-ion El mass 
spectrum. The extensive fragmentation that is produced during El is useful as a fingerprint 
which can be used for identification of the compound. Positive-ion El mass spectra are the
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most common type of mass spectra, and identification can often be achieved through a 
computer search of an extensive library of El spectra, such as the NIST library. The 
conditions for obtaining positive-ion El spectra are well standardized. Therefore, positive- 
ion El was our method of choice.
A. Peak Criteria
Three criteria were utilized to determine the appearance of “peaks” on the GC-MS. 
First, the signal-to-noise ratio (over the background) has to exceed the mean area of six 
random data points (three from each side of the peak in question) plus three standard 
deviations. Second, the retention time of the compound of interest should match the 
retention time of extracted standards of commercially prepared quality control samples 
(Biorad or Utak), or a prepared bovine whole blood sample fortified with primary 
standards, or a mixture of primary standards prepared in methanol (or other suitable 
standards). The retention time must be within +/- 3% of the aforementioned standards. In 
addition to the criteria mentioned above, the third criteria involves obtaining a match 
quality (reported by the instrument) which exceeds 850 counts for full scan El data.
VI. Sample Size
In forensic settings, one of the key issues in any analysis is availability of a 
sample. This becomes exceedingly important in analysis of hair samples obtained from 
deceased individuals whose remains have been returned to the family. Sample size 
becomes a factor if the quantity of sample is limited and multiple analyses are needed for 
presumptive screening and confirmation purposes. To use available hair samples most 
efficiently the smallest sample possible was analyzed in order to conserve the finite
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supply of hair yet still be above the limit of detection of the analytical method; also, the 
presumptive screen and confirmation was performed on the same extract. To address the 
issue of sample size we fortified four hair samples weighing 5,10,25, and 50 milligrams 
with equivalent drug concentrations (in nanogram drug/milligram hair). The digestion, 
extraction, and analytical procedures as described in Appendix One were followed. The 
minimum samples size of hair that provided reproducible results and detectable quantities 
of drugs was 10 milligrams. This sample size coincides well with values found in the 
literature. (30,29, 31) Presumptive positive and confirmatory analysis were preformed on 
the same extract in order to conserve the initial supply of sample. The hair supernatant is 
split after the final reconstitution (350 micro-liters methanol) into two samples: 300 micro­
liters of extract is pipetted into an EMIT plastic sample cup and 50 micro-liters is pipetted 
into an auto-sampler vial for analysis on the GC/MS. The advantages of splitting the 
sample are twofold: first, presumptive and confirmatory screens are run using one 
extract: ;second, we bypass evaporation and decontamination effects (from the plastic 
EMIT sample cup) afforded by the first screen.
Chapter 3. Materials and Methods
/  Analytical reagents
HPLC grade reagents were obtained from Fisher Scientific; saturated borate 
solution (pH 9.2) was prepared in distilled water; 1 N hydrochloric acid and 5 N sodium 
hydroxide were prepared in distilled water. Drugs used to fortify negative hair were 
purchased from Fisher Scientific. A 1 milligram/milliliter stock solution of 
benzphetamine was prepared in methanol to serve as the internal standard. Drug standards 
(multiple drug solutions prepared in methanol), were also prepared 1 milligram/milliliter 
concentration and served as positive controls. Working solutions were prepared by 
dilution of the stock solution in methanol to 10 nanogram/microliter concentrations. Drug 
solutions were stored at -20 degrees Celsius until use. Hair samples (fortified and case 
samples) were stored at ambient temperature until use.
77. Hair preparation.
Negative control hair samples were collected from several drug free volunteers 
(determined by urine analysis) throughout the length of the project. Both individuals were 
female with brown hair. Hair samples were cut from distal portions of the hair fiber. 
Negative samples were cut into 1 centimeter sections, and 10.0 (+/- 0.1) milligrams of the 
sectioned hair was used as a control. Negative controls were fortified with 250 nanograms 
of an internal standard, benzphetamine. Hair samples were allowed to fortify for 24 hours 
to allow the drug to sufficiently adhere to the hair fiber. Upon conclusion of the 24 hours, 
the fortified samples were placed under a gentle stream of nitrogen to evaporate off the 
drug solution. Positive controls were prepared in a similar manner as negative controls.
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However, in addition to 250 nanograms internal standard, 2000 nanograms of the 
following drugs were added to the hair sample: amphetamine, methamphetamine, 
meperidine, oxycodone, codeine, amitriptyline, lidocaine, caffeine, and papaverine. 
Fortified hair samples were not washed prior to digestion to ensure that 100 percent of the 
internal standard and grob drugs (drugs used to fortify positive controls) were available for 
digestion and extraction. (36) Non-fortified positive samples (i.e., case samples) were 
collected from deceased individuals across the state of Montana. Samples were pulled 
from the subject’s scalp in the posterior vertex region of the head. If head hair was not 
available, pubic and axilliary hair was collected. The samples were sent to the Montana 
State Crime Laboratory in hair collection kits which were prepared at the crime lab and 
distributed to county coroners during preliminary stages of this research project. Case 
samples were stored at ambient temperatures in the collection kits. Each sample was 
washed as described in Appendix One. The sample size of the case sample was equal to 
that of the control samples. Case samples were spiked with 200 nanograms of internal 
standard just prior to the extraction step, 
in. EMIT Analysis
The presumptive screen is performed on a SYVA™ ETS^^ Plus System. The 
photometer uses a tungsten-halogen 14 volt bulb as the light source with an operating 
range of 0.000-2.000 absorbance units and wavelength of 340 (+/- 2) nanometers. Each 
analysis uses 17.5 micro-liters of reagent A and reagent B, and 5.0 micro-liters of the hair 
supernatant sample. The accuracy of the instrument is +/- 2.0 % of the sampled volume, 
and +/- 2.5 micro-liters +/- 2.0% of dispensed volume. The throughput of the instrument
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is approximately 73 tests per hour. Data output is expressed using a thermal dot matrix 
printer. The external computer is a RS-232C with switch selectable baud rate. 
rV. Chromatography.
The confirmatory analysis is performed on a Finnigan MAT™ GCQ ion trap mass 
spectrometer, with a A200S autosampler. The injection port temperature is maintained at 
230 ° Celsius. Separation is achieved on a silicon capillary column (30 m x 0.25 mm i.d., 
J & W DB5MS). Electrons are emitted by a filament in the ion source and are accelerated 
to a kinetic energy of approximately 70 electron volts. Transfer line temperature is 200 ° 
Celsius and ion source temperature is 230 ° Celsius. The GC temperature program is as 
follows: initial temperature, 80 ° Celsius, hold 1.00 minutes(s); 30 ° Celsius/minute 
increase until 200 ° Celsius; 10 ° Celsius/ minute increase until 300 ° Celsius; hold for 5 
minutes; total run time, 20 minutes. The scan mode is as follows: begin scan at 3 minutes; 
full scan mode; mass 40-400 atomic mass units. The GCQMS detector utilizes an ion trap 
mass analyzer with an ion source external to the mass analyzer.
Chapter 4. Analysis of Non-fortified Samples (Pilot Case)
/. Pilot Case
To determine if the digestion-extraction procedure designed using fortified hair 
would extract drugs in non-fortified (positive) hair, a sample of hair collected by the state 
pathologist from a deceased person in a forensic case was analyzed. The case history of 
the decedent who donated the hair was reviewed prior to analysis to ensure that the 
individual participated in drug use, therefore the hair sample had high probability of 
containing endogenous drug.
All cases analyzed following the pilot case would be performed in a blind study. 
The case history for all samples would not be known to the investigator until after the 
conclusion of the hair analysis. After the hair was analyzed, the case history of the 
individual, including the results of the toxicological analysis, was reviewed for 
comparison purposes.)
A. Case History
A deceased 44 year-old white male was admitted to a local hospital in early 
October.. The decedent was discovered in a local park and was listed as an apparent 
dumped body by the county coroner. The body was beginning to undergo decomposition 
processes. A urine specimen was drawn by the hospital staff and tested for drugs of abuse 
using an ELISA (immunoassay) method. The specimen tested positive for cocaine 
metabolites and opiates. The subject was relocated to the Montana State Crime 
Laboratory for further investigation.
B. Analysis of Toxicological Specimens
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The next day an autopsy was performed by the state pathologist and additional 
toxicological specimens (blood, urine, vitreous humor, hair, and the following tissues: 
liver, kidney, and brain) were collected for analysis. Urine spot test for salicylates, 
phenothiazenes, imipramine, and placidyl were unremarkable for the decedent. Samples 
run on the EMIT revealed an unremarkable blood specimen while the urine specimen was 
positive for cocaine metabolites and opiates, and had an increased rate for 
amphetamine/amphetamine-like analogs. Basic extraction of the urine specimen (analyzed 
on the GC-Nitrogen Phosphorous Detector and confirmed on the GC/MS) confirmed the 
presence of methamphetamine, nicotine, cotinine, carisoprodol, cocaine, hydocodone, 
morphine, codeine and fentanyl. Acidic/neutral extraction of the blood (analyzed and 
confirmed on the GC/MS) confirmed the presence of meprobamate, carisoprodol, and 
fentanyl. Analysis of the blood for alcohol by headspace autosampler was unremarkable. 
Approximately two months after the autopsy was performed and the biological fluids were 
analyzed, two samples of the decedents hair, weighing 20 and 60 milligrams, were 
analyzed.
C. Analysis of Hair
The hair sample was cut into 1 centimeter lengths at the most proximal portion of 
the hair shaft. Decomposition of the body and skin slippage did not allow the hair to be 
pulled cleanly from the scalp. Therefore, skin cells were removed from the hair sample 
with small tweezers until visual inspection verified a clean hair sample. The hair was 
weighed into 20 and 60 milligram specimens and these two samples were washed as 
described in Appendix One. The wash of each sample was analyzed parallel to each hair
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sample on the EMIT and GC/MS. Digestion and extraction procedures as described in 
Appendix One were followed to prepare the hair sample for instrumental analysis. Quality 
controls (positive and negative) were analyzed parallel to the case sample to evaluate 
instrumental performance (precision and accuracy) for the EMIT and GC/MS.
EMIT analysis of the wash was unremarkable for both specimens (20 and 60 
milligram samples). The larger hair specimen (60 milligrams) tested positive for 
amphetamine/amphetamine-like compounds, and resulted in increased rates for cocaine, 
barbiturates, benzodiazepines, and opiates. The smaller hair specimen (20 milligrams) 
tested positive for amphetamine/amphetamine-like compounds.
GC/MS analysis of the wash for both specimens was unremarkable. GC/MS 
analysis of the hair specimens revealed a much cleaner spectrum for the smaller sample 
versus the larger sample. Although the larger sample tested positive for more assays on 
the EMIT, more contaminants were apparent on the GC/MS (as identified by the 
appearance of many more extraneous peaks resulting in a noisy baseline). Nicotine, 
phenethylamine (a by-product of decomposition) and the internal standard, benzphetamine 
were confirmed. In the smaller sample, nicotine, phenethylamine, and benzphetamine 
were also confirmed. This sample was much cleaner than the larger sample, and mass 
addition revealed the molecular ions for codeine, although the presence of this drug could 
not be confirmed.
Two hair samples (20 milligrams each) were prepared (and washed) as described 
above. After the initial digestion step, one of the samples was extracted using a standard 
benzoglecgonine (primary metabolite for cocaine) extraction procedure and the other
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sample was extracted using a standard acidic/neutral procedure (Appendix One). Both of 
these samples were analyzed using GC/MS. The presence of cocaine or cocaine 
metabolites could not be confirmed. However, analysis of the acidic/neutral extract 
confirmed the presence of phénobarbital in the hair.
D. Discussion
The profile of the hair analysis may be explained in part by the following:
1.) Generally, parent compounds are found much more readily in hair versus 
their metabolites. (37)
2.) Of the 10 drugs found in the blood (3) and urine (9), cotinine, 
meprobamate, and codeine are all metabolites.
Interpretation of the results must be made with caution. The decedent’s interest in drugs 
of abuse is supported by the fact that phénobarbital was discovered in the hair sample. In 
addition, the lion-scheduled drug nicotine was also confirmed in the hair sample. The 
wash extracts were unremarkable for either of the two drugs confirmed in the decedents 
hair, indicating that the drugs were from endogenous origin. Interestingly, a by-product of 
decomposition (phenethylamine) was confirmed in the hair sample, however, there was no 
trace of the contaminant in the wash extract. This indicates that the contaminant was 
deposited within the hair shaft itself, after death.
In summary, the initial digestion-extraction procedure confirmed the presence of 
one drug and led investigators to further analysis which ultimately confirmed the presence 
of a second drug of abuse. These findings indicate the procedure designed using fortified 
positive hair samples can extract non-fortified positive hair samples (endogenous drug)
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and lead to the qualitative determination of drugs of abuse in hair.
E. Reproducibility
To further ensure instrumental integrity, a different case was submitted to duplicate 
analysis. This experiment was designed to test the reproducibility of the analytical 
procedure (by analyzing the same extract in repeat series within a twenty-four hour time 
period), and to test the reproducibility of the methodology (by splitting one hair sample 
and running parallel digestion/extraction). In other words, we wanted to identify and 
confirm the same drugs each time we submitted the hair sample to our analytical and 
bench methods. The decedent was a male subject with dark brown/ black hair. Analysis 
of decedent's urine specimen revealed the presence of acetaminophen, meprobamate, 
caffeine, carisoprodol, propoxyphene, norpropoxyphene, amitriptyline, and nortriptyline. 
Analysis of the decedent's blood tested positive for the following compounds: caffeine, 
propoxyphene, norpropoxyphene, acetaminophen, ibuprofen, carisoprodol, and 
meprobamate. A 20 milligram hair sample was split into two portions and analyzed 
separately, following the wash and digestion/extraction procedures described in Appendix 
One. Results for both fractions of the split hair sample resulted in the following 
confirmations: nicotine, meprobamate, carisoprodol, propoxyphene, norpropoxyphene, 
and amitriptyline, see Appendix Three . Analysis of the wash (for both fractions) revealed 
the presence of carisoprodol and propoxyphene. The presence of compounds in the wash 
promotes cautious interpretation of the hair results. Since the other five compounds 
identified in the hair samples did not appear in the wash, it might be infered that the two 
compounds in the wash were extracted out of the hair by the water. It is interesting to note
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that the presence of two metabolites (meprobamate and norpropoxyphene) were identified 
in the hair shaft. Generally, the analysis of hair for metabolites of parent compounds 
present a difficult problem for forensic scientists (see Chapters 4 and 5 for discussion of 
metabolites in hair).
To strengthen the validity of instrumental analysis, two hours after the first two 
samples were analyzed, one of the samples was analyzed again. The second analysis 
confirmed the presence of all compounds present in the first analysis, see Appendix Three.
The combination of the reproducibility experiments for both the analytical 
procedure and bench methodology strengthen the effectiveness of the detection protocol.
Chapter 5. Results of Hair Analysis for 29 Case Samples 
/. Results
Hair samples were collected by county coroners and the state pathologist 
throughout a time period of 22 months. Samples were stored in their original collection 
kits at ambient temperature until analysis. Upon analysis, cases were randomly grouped 
into sets of five and analyzed in parallel with fortified positive and negative hair standards, 
and a positive drug control. Each case sample was washed according to the procedure 
described in Appendix One.
The results of 29 case studies are summarized in Table 2. In addition to the hair 
analysis and toxicological results, gender, age, hair color, and submitting agency were 
recorded. Seven female and 22 male subjects participated in the study.
Case
Number
Agency Gender Hair
Color
Drugs in 
Urine
Drugs in 
Blood
Drugs in 
Hair
Drugs in 
Wash
15-T Benefis
West
M Dark
Brown
none
detected
none
detected
nicotine none
detected
983355 Benefis
West
F Dark
Brown
N/A (vitreous)
none
detected
none
detected
none
detected
122298 Benefis
West
M Brown none
detected
none
detected
none
detected
none
detected
988037 Hill Co. 
Sheriff
M Brown none
detected
none
detected
none
detected
none
detected
982465 Missoula
Co.
Sheriff
M Brown
Gray
N/A ethanol
caffeine
nicotine
lidocaine
nicotine
hydro-
codone
none
detected
983358 Benefis
West
M Brown N/A ethanol
ibuprofin
nicotine
aspirin
none
detected
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Case
Number
Agency Gender Hair
Color
Drugs in 
Urine
Drugs in 
Blood
Drugs in 
Hair
Drugs in 
Wash
983538 Benefis
West
M White nicotine
caffeine
none
detected
aspirin none
detected
990056 Benefis
West
M Black caffeine
diphen­
hydramine
caffeine aspirin none
detected
983970 Benefis
West
M Gray none
detected
none
detected
nicotine none
detected
983415 F Blond No
Suitable
Sample
No
Suitable
Sample
nicotine
aspirin
none
detected
981387 Missoula
Co.
Sheriff
M Dark
Brown
ephedrine
pseudo-
ephedrine
nicotine
cotinine
caffeine
ethanol
caffeine
nicotine
ephedrine
none
detected
981426 F Brown methadone
pro­
methazine
codeine
diazepam
nordiazepam
hydrocodone
hydroxine
paroxetine
nicotine
caffeine
ibuprofen
aspirin
meprobamate
carisoprodol
nicotine
ephedrine
phen-
iramine
hydro­
codone
norpro-
poxyamide
none
detected
981691 Madison
Co.
Coroner
F Black N/A ethanol
nicotine
cotinine
caffeine
nicotine
diphen-
hydrinate
diphen-
hydrinate
981329 Lake Co. 
Coroner
F Dark
Brown
amphet­
amine
methamphet-
amine
cannabinoid
methamphet-
amine
methamphe
t-amine
ephedrine
none
detected
981743 Ravalli
Co.
Coroner
M Light
Brown
N/A ethanol
nicotine
nicotine
lidocaine
hydrocodone
none
detected
983636 Richland
Co.
Coroner
M Brown
with
White
N/A none detected nicotine none
detected |
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Case
Number
Agency Gender Hair
Color
Drugs in 
Urine
Drugs in 
Blood
Drugs in 
Hair
Drugs in 
Wash
982301 Beaverhead
Co.
Coroner
M Light
Brown
no suitable 
samples
no suitable 
samples
nicotine
phenethy
l-amine
propyl-
phenethy
1-amine
none
detected
980735 Ravalli
Co.
Coroner
M Brown nicotine
cotinine
cannabiniod
ethanol
caffeine
cannabinoid
nicotine none
detected
983356 Toole Co. 
Coroner
M Dark
Brown
ephedrine
psuedo-
ephedrine
nicotine
cotinine
caffeine
ethanol nicotine none
detected
983357 Cascade
Co.
Coroner
M Dark
Brown
nicotine
cotinine
mepro­
bamate
carisoprodol
amitrip­
tyline
norami-
triptyline
oxycodone
cannabinoid
nicotine
amitriptyline
norami-
triptyline
diazepam
nor-diazepam
oxycodone
carisoprodol
mepro­
bamate
nicotine
amitrip­
tyline
oxycodone
carisopro­
dol
none
detected
980819 Lake Co. 
Coroner
M Brown caffeine caffeine
lidocaine
nicotine none
detected
980103 Gallatin
Co.
Coroner
F Black N/A ethanol nicotine none
detected
983372 Benefis
West
F Black N/A caffeine nicotine none
detected
980890 Ravalli
Co.
Coroner
M Brown N/A ethanol
diphen­
hydramine
propoxy­
phene
norpro­
poxyphene
amitriptyline
norami-
triptyline
nicotine
diphen­
hydramine
amitrip­
tyline
none
detected
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Case
Number
Agency Gender Hair
Color
Drugs in 
Urine
Drugs in 
Blood
Drugs in 
Hair
Drugs in 
Wash
980609 Flathead
Co.
Coroner
M Brown nicotine
caffeine
ethanol
nicotine
caffeine
nicotine none
detected
983582 Cascade
Co.
Coroner
M White caffeine
aspirin
caffeine none
detected
none
detected
In the population of case samples, 38 confirmations occurred in urine, 35 
confirmations in occurred blood, and 40 confirmations in the hair samples. The above 
cases represent diverse parameters (including gender, age, environment, time of collection 
after death, and cause of death). These parameters, combined with the relatively small 
number of samples, precludes broad conclusions. However, several trends are observed 
in the data obtained from the experiment:
1.) In eight cases metabolites of active compounds were identified in the blood or 
urine and did not appear in the hair. While metabolites for methadone, propoxyphene, 
morphine, marijuana, PCP, cocaine, and tricyclic antidepressants have been shown to bind 
to hair, to achieve detection at the lower drug concentrations, derivatization of the hair 
samples is often required. (28,38-42) For some drugs such as amphetamine, PCP, and 
marijuana, the metabolites are either in extremely low concentration in the hair (relative to 
the parent compound) or non-detectable.(38) Our data supports these observations.
2.) A variety of drugs which were not identified in the other biological samples 
(25 in blood, and 10 in the urine) were confirmed in the hair. These findings support the 
role of hair analysis as a useful supplemental screen in toxicological analysis. A more 
complete drug history may be afforded when hair analysis is combined with the traditional
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forensic toxicology protocol. In addition, ten confirmations of drug use initially identified 
in the blood were observed in the hair, and eleven confirmation of drug use identified in 
the urine were supported by hair analysis.
3.) Drugs were identified 40 times in the hair samples. However, only one of the 
wash samples tested positive for drugs. The drug confirmed in the wash of case 98-1691 
was diphenhydrinate (Dramamine). This correlates to a 2.50% extraction efficiency of the 
wash solvent (as defined by number of drugs extracted in the wash divided by total 
number of drugs extracted in the hair sample).
4.) Using the digestion-extraction protocol described in Appendix One, drugs 
belonging to the benzodiazepine drug class were not detectable. Diazepam, a prototypical 
benzodiazepine, has a pKa of approximately 3.4, which is much lower than that of drugs 
classified in the other six drug classes. The absence of the benzodiazepines in the hair 
samples could be the result of an extreme pH difference between our digestion-extraction 
media and the drug.
5.) Three cases (983355, 122298, and 988037) tested negative for all three 
specimens analyzed. If the detection protocol is limited to drugs of abuse, 14 of the 26 
cases tested negative for drugs in the blood and urine specimens. The 14 corresponding 
hair samples also tested negative for drugs of abuse.
Chapter 6. Conclusions
/. Discussion
A. Drug Structure
The difference in appearance of drug in the blood, urine, and hair specimens can 
be explained in part by structural parameters of the drugs (lipophilicity, pKa) and different 
pharmacokinetic behavior (half-life, metabolism, protein binding, and pH). (18) For 
example, the half-life and metabolism rate of a drug relate directly to the duration of 
exposure to hair binding sites. Protein binding and pH of a drug effect possible 
competing reactions with hair binding sites and overall incorporation into the hair fiber 
(see Figure 7). In several cases, a qualitative trend is seen between drugs identified in all 
samples (983355,122299,988037, 981426, and 983357), however, there appears to be a 
very strong deviation for some of the subjects (983358,983356, and 980890). This same 
phenomena was reported in the literature for therapeutic drugs as well as illicit drugs of 
abuse. (43)
B. Pigmentation
Most (69%) of the individuals included in this study had brown or black hair. As 
detailed earlier (Chapter 1, Section III), color is determined by the quantity of 
pheomelanin and eumelanin present in hair. Black and brown hair contain more 
eumelanin than blond or white hair. Unfortunately, there are few studies on the effect of 
hair color on the incorporation of drugs of abuse into human hair. Several laboratories 
have reported that hair color is responsible for the greater accumulation of haloperidol and 
ofloxacin in black hair than in white hair. (44) Other investigators have demonstrated that
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drugs of abuse bind to the hair of albino animals in amounts that are similar to those found 
in pigmented animals. (45) These findings suggest that drugs need not be incorporated 
into the melanin pigment. This paper reports the finding of nicotine and acetaminophen in 
2 samples of white/blond hair. The small sample population precludes any generalizations 
from the data presented here regarding pigmentation and the binding of drugs to hair.
C. Individual Cases
1. Interestingly, several cases present unique information regarding the 
presence of nicotine in the decedents hair samples. In 15-T, 983358, 
983970, 983356, and 980819 nicotine was not identified in either the blood 
or urine, yet it was confirmed in the decedent’s hair. One hypothesis might 
be that these subjects did not ingest the compound, that the drug was a 
contaminant on the hair fiber (exogenously deposited from the 
environment). However, nicotine was not identified in the wash extracts 
for any of the hair samples. It can be inferred that the compound was 
endogenous, and had been cleared from the circulatory system prior to 
death.
2. Two cases in particular reinforce the need for hair analysis as a supplement 
to traditional methods. In these cases (98-2301, 98-3415), no suitable 
samples were obtained in the toxicological collection kits. Due to 
decomposition, analysis of the biological fluids was futile. Analysis of the 
hair samples revealed the presence of nicotine and acetaminophen, in 
addition to numerous products of decomposition. While nicotine and
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acetaminophen are not drugs of abuse, they offer further evidence to 
support the usefulness and applicability of hair analysis in forensic 
screening.
3. This procedure was particularly sensitive for opioids, within the limitations 
of drugs detected by our analytical methods. With only one exception 
(when codeine was identified in the biological fluid and not in the hair), all 
opioids were confirmed in the hair if identified in other biological samples .
4. The presence of lidocaine in decedent’s blood or urine samples represents 
several interesting possibilities. Lidocaine is a local anesthetic commonly 
administered to patients in crisis situations upon arrival to hospital 
facilities. In 982465 and 980819 lidocaine was confirmed in the blood or 
urine but was not identified in the hair sample. Two explanations for this 
discrepancy are:
- lidocaine does not extract well using the protocol and was present in the 
hair, but was not detected by the bench/analytical methods (or lidocaine 
does not fully integrate the hair fiber);
- lidocaine was administered at an emergency facility immediately prior to 
the death of the individual, but the time interval to death was so short the 
drug did not penetrate the hair follicle of the individual.
While the hospital records for the two decedents involved in the above 
cases are not yet available to this investigator, the identification of lidocaine in two 
additional, separate hair samples has shown that this compound does bind to the
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hair shaft and will be extracted by the procedure. Further investigation is needed 
to determine if the appearance of lidocaine in 982465 and 980819 is a result of 
emergency treatment.
5. In case 122298, all three samples (blood, urine, and hair) tested negative for 
the presence of drugs for the seven drug/drug class assays. This case serves 
as an excellent “negative control” for our research design. Fourteen cases 
were negative for drugs of abuse (or prescription drugs) analyzing the 
blood or urine, and all fourteen hair samples were also negative. These 
findings need to be interpreted with care. At this point in the science of 
hair analysis, there is not sufficient data to support the statement that a 
negative hair sample, without additional information from blood or urine 
samples, indicates that the individual is a drug free. Interpretation of 
negative, or drug free hair samples, gives information of drug history at the 
point in time designated by the length of hair (using an average growth rate 
of one centimeter of hair per month). In other words, one month prior to 
death (as in our research protocol) the individual was drug free, within the 
limitations of our experimental design.
77. Summary
One of the greatest challenges in the area of hair analysis has been the development 
of sensitive MS technologies to provide reliable confirmation of drugs in toxicological 
analysis. This paper describes a novel approach to the confirmation of endogenous 
compounds from seven different drug classes using one general, comprehensive digestion-
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extraction procedure. Instrumental techniques, hair collection protocol, and sample 
preparation described in this paper stand as testimony to the evolution of criteria for 
confirmation of drug presence that are generally recognized as scientifically sound. Hair 
analysis proves to be a very useful tool for qualitative retrospective evidence of drug 
intake within a wide time window. The results described in this report further current 
understanding of the general parameters of drug disposition in hair. In order to get more 
detailed information about the timetable of drug consumption, drug binding kinetics, and 
quantitative aspects of drugs in hair, much more experimental effort is needed to exhaust 
the possibilities of the method, which are more or less dictated by individual cases. The 
relationship between new and traditional approaches to forensic analysis should not be 
viewed as one of competition between blood, urine, and hair analysis, but rather as one 
wherein the different techniques are in synergistic interaction in solving the unique 
forensic challenges associated with the identification and timing of drug use. In this 
respect, the particular value of hair analysis lies in the ability to determine long-term usage 
of drugs of abuse rather than the short-term elimination provided by blood and urine.
Chapter 7. Decontamination Revisited
/. Endogenous versus Exogenous Drug Binding
One key issue regarding drug analysis in forensic cases is the potential for 
identification of drugs that have been bound exogenously, rather than via ingestion. 
Decontamination steps are taken (washing the hair sample) prior to analysis of the hair 
sample to ensure that the environmental contribution (from vapors, smoke, or external 
residue) is minimized. Lack of availability of good endogenous samples to compare with 
exogenous samples makes validation of any wash protocol difficult. One way to 
circumvent this issue, and remove the possibility of extracting the endogenous drug from 
the hair shaft, is to determine the location of the drug on, or in, the hair shaft.
A novel approach to differentiate between endogenous and exogenous drug 
exposure was explored in one of the experiments designed using a rat model. In this 
experiment, the lower dorsal region of three Sprague-Dawley rats were shaved on days 0 
(the negative control), 7, and 21. In addition to the above samples, a positive control was 
prepared using negative rat hair and soaking the rat hair in a solution of codeine dissolved 
in methanol. Each rat was injected with 20 milligram codeine/ killogram animal on day 0, 
7, and 14. All samples underwent the same wash procedure described in Appendix One. 
Upon conclusion of the decontamination procedure and a one day drying period, all hair 
samples were embedded in paraffin , sectioned using a microtome, and stained using the 
monoclonal antibody protocol described in Appendix Two.
The negative control was characterized by the lack of antibody binding to the hair 
section through microscopic visual observation, Figure 8 (A). The positive control did
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have apparent antibody binding sites on the exterior, or outside of the hair fibers. Figure 8 
(B). These binding sites were displayed as dark brown domains on the exterior surfaces of 
the hair fiber. The hair samples collected on day 21 from the rat’s lower back, which 
contained endogenous drug, differed from the positive and negative controls. The 
endogenous samples were stained on the inner portions of the hair shaft, towards the 
medulla and cortex of the hair fibril. Figure 8 (C). These findings are supported by data 
obtained in other research facilities analyzing horizontal sectioning of hair shafts using 
infrared microscopy. (46)
To expand upon the findings in the above study, a similar protocol was applied to a 
human model. In this experiment, 10 milligrams of positive hair (250 nanograms 
hydrocodone solublized in methanol fortified onto the hair fibril for 8 hours, then 
evaporated to dryness) and 10 milligrams negative hair standards were placed in a drying 
oven (70° Celsius) overnight. This drying step was incorporated to replace the “fixing”, or 
dehydrating step in the rat model. The rationale for the drying step was based upon the 
discovery of wash solvents extracting the drugs from hair samples. By avoiding 
unnecessary solvent interaction, an attempt to avoid extracting the drug from our hair 
sample into the fixing reagents was explored. The positive and negative controls were 
embedded in paraffin, sectioned (at 5 microns), mounted, and immunocytochemistry was 
performed as described in Appendix Two. In addition to the controls, two cases which 
tested positive for opioids, (981426 and 981743; hydrocodone) were also analyzed.
II. Results
The human hair controls provided much differentiation between the staining
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Figure 8: Photographs of (A) Negative rat hair, (B) Fortified positive rat hair; codeine, and (C) Non­
fortified positive rat hair (Staining with DAB)
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patterns of drug versus non-drug controls, Figure 9. The negative (or drug-free) hair 
sample. Figure 9 (A) has little “background" staining compared to the fortified positive 
control, Figure 9 (B). All of the staining in the positive control is exterior to the cuticle, 
with very little stain penetrating the cortex. It is interesting to note that the two hair 
specimens chosen for the endogenous (case) study appear to bind hydrocodone in different 
areas of the inner hair shaft. Case sample 981743, Figure 9 (C) is stained in the medulla 
region of the hair fiber, whereas 981426, Figure 9 (D), a hair sample without a medulla, is 
stained in the outer cortex region of the hair shaft.
It is important to note that no histochemical work involving hair analysis is 
available to this author for comparison and this work serves only to initiate a preliminary 
understanding of the possibilities available through immunocytochemistry for the 
differentiation of endogenous versus exogenous drug binding. Further research is required 
to determine is this approach is viable for additional drugs of abuse.
HI. Discussion
This work offers exciting evidence for a new detection method of endogenous 
versus exogenous drug deposition. Within a limited human model, differentiation 
between localization of endogenous and exogenous hydrocodone has been observed. The 
application of immunocytochemistry to other drugs and hair types has not been explored. 
While further research is need to expound upon these preliminary data, the significance of 
discrimination between “clean” and contaminated hair samples in forensic cases can be 
expected to escalate as the science of drug analysis in hair becomes more proficient.
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Figure 9: Photographs of (A) Negative hair, (B) Fortified positive hair, hydrocodone, (C) Case 981426,
and (D) Case 981743 (Stained with DAB)
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Figure 9: Photograph of (A) Negative hair, (B) Fortified positive hair, hydrocodone, (C) Case 981426,
and (D) Case 981426 (Stained with DAB)
Appendix One
Procedure for Drug Analysis in Hair: Decontamination, Digestion, and 
Extraction
Decontamination Procedure
A. Hair sample is removed from hair collection kit and approximately 10-15
milligrams of the proximal portion of the hair shaft is placed into a 10
• milliliter screw-capped test tube. The weight of the hair sample is 
recorded.
B. 2 milliliters of de-ionized water is added to the hair sample with constant 
agitation for a contact period of 15 seconds. The water is decanted off the 
hair sample and collected in a 10 milliliter screw-capped test tube. This 
process is repeated once more (for of total of 4 milliliters of wash). Both 
washes are combined in one test tube. The hair specimen is allowed to air 
dry overnight prior to being digested. The wash is extracted as described 
below.
C. 6 milliliters of n-butyl chloride is added to the 4 milliliters of wash in the
screw-capped test tube. The tube is placed on a rotary shaker for 10 
minutes, centrifuged at 3000 rpm for 5 minutes, and the n-butyl chloride is 
decanted into a 10 milliliter conical tube. The solvent is evaporated to 
dryness with the aid of nitrogen in a warm water bath (40° C).
D. 350 micro-liters of HPLC grade methanol is added to the conical tube with
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quick vortex (10 seconds). 300 micro-liters of the sample is place in EMIT 
sample cups and 50 micro-liters of the sample is place in the GC/MS auto­
sample vials for further analysis, 
n. Digestion of Hair
A. 1 milliliter saturated sodium borate solution is added to the 10-15 milligram
hair sample (after decontamination) with quick vortex (10 seconds). 2 
milliliters of sodium hydroxide is added to the hair and the tube is placed in 
a warm water bath (40° C) with constant agitation (using a micro-spin- 
vane) for 3-4 hours. The digestion time will vary depending on the 
thickness of hair being analyzed. The tube is removed from the water bath 
when the hair fibers appear to be translucent and begin to curl. Upon 
removal from the water bath, the tube is centrifuged at 3000 rpm for 10 
minutes, and the supernatant is collected in a 10 milliliter screw-capped test 
tube.
III. Extraction of Drugs from Hair (Analysis of Basic Drugs: Using a Liquid/Liquid
Extraction)
A. 3 milliliters n-butyl chloride and 200 micro-liters internal standard are
added to the digestion supernatant and the tube is placed on shaker table for 
10-15 minutes and centrifuged for 5 minutes. The supernatant is collected 
(n-butyl chloride) in a 10 milliliter conical tube. 3 drops (approximately 50 
micro-liters) of 1% methanolic hydrochloride is added to the tube and the 
solvent is evaporated with the aid of nitrogen in a warm water bath (40° C).
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B. 350 micro-liters of HPLC grade methanol is added to the conical tube with
quick vortex (10 seconds). 300 micro-liters of the sample is place in EMIT 
sample cups and 50 micro-liters of the sample is place in the GC/MS auto­
sample vials for further analysis.
IV. Extraction of Drugs from Hair (Analysis of Acidic/Neutral Drugs: Using a
Liquid/Liquid Extraction)
A. Pipette 2 milliliters of the digestion supernatant into a 15 milliliter screw- 
capped test tube. Add 200 micro-liters internal standard and 1 milliliter of 
saturated ammonium chloride solution. Quick vortex and add 8 milliliters 
of ethyl acetate into tube with gently agitation for 1 minute. Centrifuge 10 
minutes at 3000 rpm and decant upper solvent to conical tube. Evaporate 
to dryness with the aid of nitrogen in a warm water bath.
B. Add 0.5 milliliters of hexane to each tube with quick vortex. Add 50 
micro-liters acetonitrile with quick vortex and centrifuge for 1 minute at 
1000 rpm. Aspirate and discard the upper solvent layer and transfer 
acetonitrile layer to auto-sampler vials.
V. Extraction of Drugs from Hair (Benzoglecognine Derivitization: Using a
Liquid/Liquid Extraction)
A. Add 1 milliliter pH 7 buffer and 6 milliliters 9:1 chloroform: isopropyl to
the digestion supernatant. Agitate on shaker table for 5 minutes. 
Centrifuge (5 minutes at 3000 rpm), decant lower layer to 10 milliliter
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conical tube and evaporate to dryness with the aid of nitrogen in a warm 
water bath.
B. Add 100 micro-liters of DMF and DMF dipropylacetal to the conical tube
and reflux 30 seconds with air cool condenser. Cool. Pipette 1 milliliter 
sulfuric acid (1 normal) with quick vortex, and 3 milliliters n-butyl 
chloride. Vortex and centrifuge, discard upper layer. Adjust pH to 9 with 
carbonate buffer (approximately 100 micro-liters). Add 50 micro-liters 
chloroform to conical tube and vortex. Transfer to auto-sampler vial for 
further analysis.
VI. Extraction of Drugs from Hair (Solid Phase Extraction)
A. Collect 2 milliliters digest supernatant in test tube and adjust pH to between 
4.8 and 5.5 with acetic acid.
B. Condition the extraction column as follows:
1 X 3 milliliters chloroform; aspirate
1 X 3 milliliters de-ionized water; aspirate 
1 X 1 milliliter acetic acid (1.0 molar); aspirate
C. Load sample (digest supernatant) at 1-2 milliliters per minute.
D. Wash column as follows:
1 X 3 milliliters phosphate buffer (100 millimolar, pH 6.0); aspirate;
1 X 1 milliliter acetic acid ( 1.0 molar); aspirate;
Dry column for 5 minutes;
1 X 3 milliliters hexane; aspirate
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E. Elute acidic/neutral drugs using 2 x 2  milliliters chloroform (collect eluate 
at 5 milliliters per minute); evaporate to dryness
F. Extract and analyze acidic/neutral drugs as follows:
Add 1 milliliter hexane and 1 milliliter methanol:water (80:20) to the eluate 
with vortexing. Centrifuge for 5 minutes at 3000 rpm, aspirate and discard 
upper layer (hexane). Evaporate to dryness. Reconstitute with 100 micro­
liters ethyl acetate.
G. Wash Column with 1 x 2 milliliters methanol; aspirate; dry column for 5
minutes.
H. Elute basic drugs with 1x2  milliliters methanol: ammonia (98:4); collect
eluate at 1-2 milliliters per minute.
I. Extract and analyze basic drugs as described below:
Add 3 milliliters de-ionized water and 250 micro-liters chloroform to eluate 
and vortex. Centrifuge, aspirate, and decant as described above. Inject 
chloroform onto chromatograph.
Appendix Two
Procedure for Detection of Endogenous versus Exogenous Drug Exposure 
I. Embedding Protocol
After samples were washed (as described in Appendix One) and dried overnight, 
they were placed in marked metal screen cassettes (positive, negative, sample), then 
processed following the procedure below.
A. 3 hour soak in 95% ethanol on rotary table
B. 3 hour soak in 100% ethanol on rotary table (repeat once with fresh reagent 
for a total of 6 hours)
C. 1.5 hour soak in methyl salicylate
D. Soak overnight in fresh methyl salicylate
B. 3 paraffin soaks (each for 3 hours) changing to fresh reagent each time 
After embedding, the hair was removed from the cassettes and placed in plastic paraffin 
cups then covered in paraffin. The paraffin blocks were sectioned in 15 nanometer slices 
and mounted onto microscope slides. The mounted slices of hair were carried through the 
monoclonal protocol described below, 
n. Monoclonal Antibody Protocol
A. Deparaffinize slides as follows:
10 minutes in xylene (x3)
3 minutes in 100% ethanol (x3)
3 minutes in 95% ethanol (x3)
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3 minutes in 70% ethanol (x3)
B. After deparaffinization, rinse slides once in 0.1 molar PBS, repeat with 
fresh reagent and soak for 5 minutes.
C. 5 minute soak in PBS/BSA (250 milliliters 0.1 molar PBS + 1.25 grams 
BSA)
D. 20 minute soak with 4% NHS (12 milliliters TAB + 5 milliliters normal 
horse serum; TAB = 50 milliliters tris(0.1 molar)/BSA + 500 micro-liters 
10% sodium azide in distilled water)
E. Blocking serum was removed and primary antibody was applied (morphine 
monoclonal antibody with a Kd of 2 nanomolar for codeine; 120 micro­
liters antibody (at 500 micrograms/ 0.53 milliliters) in 2.88 milliliters 
PBS). Slides were incubated overnight at 4° C.
F. Rinse in PBS, refresh reagent and repeat for a 5 minute soak.
G. 5 minute soak in PBS/BSA
H. Incubate for 1 hour with secondary antibody, horse-anti-mouse (4 
milliliters TAB + 10 micro-liters antibody (1:400 dilution))
I. 5 minute soak in PBS, followed by 5 minute soak in PBS/BSA
J. Incubate for one hour in ABC reagent (5 milliliters PBS/BSA + 1 drop
vectastain elite A + 1 drop vectastain elite B - cover and let sit 30 minutes; 
dilute 1 milliliter of this solution with 5.7 milliliters PBS/BSA = ABC 
reagent)
K. Rinse with PBS, then soak for 10 minutes in fresh PBS
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L. Apply DAB and allow to sit for 10 minutes (4 milliliters PBS + 50 micor-
liters 0.1 molar imadizole + 1 milliliter DAB + 5 micro-liters hydrogen 
peroxide)
M. Rinse in de-ionized water. Repeat x2 using fresh water each time.
N. Dehydrate slides as follows:
5 minutes in 70% ethanol 
5 minutes in 95% ethanol 
5 minutes in 100% ethanol (x3)
5 minutes in xylene (x3)
O. Coverslip slides
Appendix Three
Chromatograms of Reproducibility Experiment
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The above chromatogram (A) is the first of two samples of hair from case 990547 
which were analyzed to test the reproducibility of the methodology. Sample S1 
(chromatogram A) and sample S2 (chromatogram C) were obtained by splitting a 20 
milligram sample of the decedent’s hair into two 10 milligram portions. Digestion and 
extraction procedures were run (in parallel) on both specimens. Both chromatograms 
show identical spectra, with the identification of six drugs and the Internal Standard 
benzphetamine (designated LS.). Chromatograms B and D are included to demonstrate 
two of the three criteria utilized for peak detection. In chromatograms B and C, the 
fragmentation pattern and retention time of a representative drug (propoxyphene) are 
shown for S 1 and S2. In addition, both samples record a library match with a “Fit” that 
exceeds the recommended 850 count. Data showing the third criteria,mean signal-to- 
noise ratio, is not shown.
To further insure instrumental integrity, the reproducibility of the analytical
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B. Fragmentation Pattern and Retention Time For Propoxyphene in S1
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C. Chromatogram of S2
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procedure was tested. Upon conclusion of the split sample analysis (as 
characterized in chromatograms A and C) a second experiment was performed using the 
same extract (SI) several hours after the original analysis. The extract was stored at 
ambient temperature upon conclusion of the original analysis until the second analysis 
was performed. Chromatogram E relates the results of this experiment. All six drugs 
identified in the original analysis (and the internal standard) were confirmed in the second 
analysis.
These findings support our belief in the reproducibility of our methodology and 
analytical procedures.
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D. Fragmentation Pattern and Retention Time For Propoxyphene In S2
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E. Second Analysis of Fraction S1
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